Covelli C, Sacchi D, Sarcognato S, et al. Pathology of autoimmune hepatitis. Pathologica. 2021;113(3):185–93.

Article  PubMed  PubMed Central  Google Scholar 

Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. The pathogenesis of primary biliary cholangitis: a comprehensive review. Semin Liver Dis. 2020;40(1):34–48.

Article  CAS  PubMed  Google Scholar 

Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. “Primary sclerosing cholangitis - a comprehensive review,” (in eng). J Hepatol. 2017;67(6):1298–323.

Article  PubMed  Google Scholar 

Engel B, Taubert R, Jaeckel E, Manns MP. The future of autoimmune liver diseases - understanding pathogenesis and improving morbidity and mortality. Liver Int. 2020;40(Suppl 1):149–53.

Article  PubMed  Google Scholar 

Manns MP, Czaja AJ, Gorham JD, et al. “Diagnosis and management of autoimmune hepatitis,” (in eng). Hepatology (Baltimore, MD). 2010;51(6):2193–213.

Article  CAS  PubMed  Google Scholar 

Manns MP, Lohse AW, Vergani D. “Autoimmune hepatitis–update 2015,” (in eng). J Hepatol. 2015;62(1 Suppl):S100–11.

Article  PubMed  Google Scholar 

Senger K, Hackney J, Payandeh J, Zarrin AA. Antibody isotype switching in vertebrates. Results Probl Cell Differ. 2015;57:295–324.

Article  CAS  PubMed  Google Scholar 

L European Association for the Study of the, "EASL clinical practice guidelines: autoimmune hepatitis," (in eng). J Hepatol. 2015;63(4):971–1004.

Primo J, Merino C, Fernández J, Molés JR, Llorca P and Hinojosa J. "[Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain)]," (in spa), Incidencia y prevalencia de hepatitis autoinmune en el área sanitaria del Hospital de Sagunto.  Gastroenterol Hepatol. 2004;27(4)239–43.

Chung Y, Rahim MN, Graham JJ, Zen Y, Heneghan MA. An update on the pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother. 2021;22(11):1475–88.

Article  CAS  PubMed  Google Scholar 

Tucker SM, Jonas MM, Perez-Atayde AR. “Hyaline droplets in Kupffer cells: a novel diagnostic clue for autoimmune hepatitis,” (in eng). Am J Surg Pathol. 2015;39(6):772–8.

Article  PubMed  Google Scholar 

Kim BH, Choi HY, Ki M, Kim KA, Jang ES, Jeong SH. “Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea,” (in eng). PLoS ONE. 2017;12(8):e0182391.

Article  PubMed  PubMed Central  Google Scholar 

Harmon EG, McConnie R, Kesavan A. Minocycline-induced autoimmune hepatitis: a rare but important cause of drug-induced autoimmune hepatitis. Pediatr Gastroenterol Hepatol Nutr. 2018;21(4):347–50.

Article  PubMed  PubMed Central  Google Scholar 

Grewal J, Doan A, Hong AS, et al. Drug-induced autoimmune hepatitis from hydralazine leading to acute liver failure and liver transplantation. ACG Case Rep J. 2019;6(10):e00252.

Article  PubMed  PubMed Central  Google Scholar 

Muratori P, Serio I, Lalanne C, Lenzi M. Development of autoimmune hepatitis after influenza vaccination; trigger or killer? Clin Res Hepatol Gastroenterol. 2019;43(6):e95–6.

Article  PubMed  Google Scholar 

Elfert KA, Qasim HM, Faisal MM, et al.  Hepatitis E viral association with autoimmune hepatitis: a viral trigger or cross-reactivity. Case Rep Gastroenterol. 2021;15(1):115–22.

Donaldson PT. “Genetics in autoimmune hepatitis,” (in eng). Semin Liver Dis. 2002;22(4):353–64.

Article  CAS  PubMed  Google Scholar 

Donaldson PT. “Genetics of liver disease: immunogenetics and disease pathogenesis,” (in eng). Gut. 2004;53(4):599–608.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Czaja AJ, Donaldson PT. “Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis,” (in eng). Immunol Rev. 2000;174:250–9.

Article  CAS  PubMed  Google Scholar 

Elfaramawy AA, Elhossiny RM, Abbas AA and Aziz HM. "HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection," (in eng). Italian J Ped. 2010;36:73.

Oliveira LC, Porta G, Marin ML, Bittencourt PL, Kalil J, Goldberg AC. “Autoimmune hepatitis, HLA and extended haplotypes,” (in eng). Autoimmun Rev. 2011;10(4):189–93.

Article  CAS  PubMed  Google Scholar 

Ma Y, Bogdanos DP, Hussain MJ, et al. “Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2,” (in eng). Gastroenterology. 2006;130(3):868–82.

Article  CAS  PubMed  Google Scholar 

Underhill JA, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G and Vergani D.

Doherty DG. Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J Autoimmun. 2016;66:60–75.

Article  CAS  PubMed  Google Scholar 

Floreani A, Restrepo-Jiménez P, Secchi MF, et al. “Etiopathogenesis of autoimmune hepatitis,” (in eng). J Autoimmun. 2018;95:133–43.

Article  CAS  PubMed  Google Scholar 

Hardtke-Wolenski M, Jaeckel E. “Mouse models for experimental autoimmune hepatitis: limits and chances,” (in eng). Digestive diseases (Basel, Switzerland). 2010;28(1):70–9.

Article  PubMed  Google Scholar 

Sakaguchi S. “Regulatory T cells: key controllers of immunologic self-tolerance,” (in eng). Cell. 2000;101(5):455–8.

Article  CAS  PubMed  Google Scholar 

Crispe IN. “Liver antigen-presenting cells,” (in eng). J Hepatol. 2011;54(2):357–65.

Article  CAS  PubMed  Google Scholar 

Ebrahimkhani MR, Mohar I, Crispe IN. “Cross-presentation of antigen by diverse subsets of murine liver cells,” (in eng). Hepatology (Baltimore, MD). 2011;54(4):1379–87.

Article  CAS  PubMed  Google Scholar 

Ehser J, Holdener M, Christen S, et al. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis. J Autoimmun. 2013;42:39–49.

Article  CAS  PubMed  Google Scholar 

Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. “Pathogenesis of autoimmune hepatitis,” (in eng). Best Pract Res Clin Gastroenterol. 2011;25(6):653–64.

Article  CAS  PubMed  Google Scholar 

Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. “T cell immunity in autoimmune hepatitis,” (in eng). Autoimmun Rev. 2005;4(5):315–21.

Article  CAS  PubMed  Google Scholar 

Fasano R, Malerba E, Prete M, et al. “Impact of antigen presentation mechanisms on immune response in autoimmune hepatitis,” (in eng). Front Immunol. 2021;12:814155.

Article  CAS  PubMed  Google Scholar 

Vuerich M, Wang N, Kalbasi A, Graham JJ, Longhi MS. “Dysfunctional immune regulation in autoimmune hepatitis: from pathogenesis to novel therapies,” (in eng). Front Immunol. 2021;12:746436.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schroder K, Hertzog PJ, Ravasi T, Hume DA. “Interferon-gamma: an overview of signals, mechanisms and functions,” (in eng). J Leukoc Biol. 2004;75(2):163–89.

Article  CAS  PubMed  Google Scholar 

Liberal R, Krawitt EL, Vierling JM, Manns MP, Mieli-Vergani G, Vergani D. “Cutting edge issues in autoimmune hepatitis,” (in eng). J Autoimmun. 2016;75:6–19.

Article  CAS  PubMed  Google Scholar